Health policy for sickle cell disease in Africa: Experience from Tanzania on interventions to reduce under-five mortality

Tropical Medicine and International Health

Volumn 20, Issue 2, 2015, Pages 184-187

  Makani, Julie ^a,b,c   Soka, Deogratias ^a   Rwezaula, Stella ^b   Krag, Marlene ^d   Mghamba, Janneth ^e   Ramaiya, Kaushik ^e   Cox, Sharon E ^a,f   Grosse, Scott D ^g  

^a MUHIMBILI UNIVERSITY OF HEALTH AND ALLIED SCIENCES   (Tanzania)

^b MUHIMBILI NATIONAL HOSPITAL   (Tanzania)

^c UNIVERSITY OF OXFORD   (United Kingdom)

^d UNIVERSITY OF COPENHAGEN   (Denmark)

^e and Children   (Tanzania)

^f LONDON SCHOOL OF HYGIENE AND TROPICAL MEDICINE   (United Kingdom)

^g NATIONAL CENTER ON BIRTH DEFECTS AND DEVELOPMENTAL DISABILITIES   (United States)

Author keywords

Africa; Childhood mortality; Health policy; Morbidity; Mortality; Newborn screening; Pneumococcal vaccines; Public health; Sickle cell anaemia; Trends

Indexed keywords

PENICILLIN V;

CHILD HEALTH; DISEASE INCIDENCE; EPIDEMIOLOGY; HEALTH POLICY; INFECTIOUS DISEASE; MORTALITY;

AFRICA; ARTICLE; BACTERIAL INFECTION; CHILD; CHILDHOOD MORTALITY; GOVERNMENT; HEALTH CARE POLICY; HEALTH PROGRAM; HEMOGLOBINOPATHY; HUMAN; INFECTION PREVENTION; NEWBORN SCREENING; NON COMMUNICABLE DISEASE; RISK REDUCTION; SICKLE CELL ANEMIA; TANZANIA; EPIDEMIOLOGY; INFANT; INFANT MORTALITY; MORTALITY; NEWBORN; PRESCHOOL CHILD;

AFRICA;

ANEMIA, SICKLE CELL; CHILD MORTALITY; CHILD, PRESCHOOL; HEALTH POLICY; HUMANS; INFANT; INFANT MORTALITY; INFANT, NEWBORN; TANZANIA;

EID: 84920984889     PISSN: 13602276     EISSN: 13653156     Source Type: Journal    
DOI: 10.1111/tmi.12428     Document Type: Article

References (20)

1. Akinyanju OO, Otaigbe AI & Ibidapo MO (2005) Outcome of holistic care in Nigerian patients with sickle cell anaemia. Clinical and Laboratory Haematology 27, 195-199.
2. Grosse SD, Atrash HK, Odame I, Amendah D, Piel FB & Williams TN (2012) The Jamaican historical experience of the impact of educational interventions on sickle cell disease child mortality. American Journal of Preventive Medicine. 42, e101-e103.
3. Hill K, You D, Inoue M & Oestergaard MZ (2012) Child mortality estimation: accelerated progress in reducing global child mortality, 1990-2010. PLoS Medicine 9, e1001303.
4. Makani J, Komba AN, Cox SE et al. (2010) Malaria in patients with sickle cell anemia: burden, risk factors, and outcome at the outpatient clinic and during hospitalization. Blood. 115, 215-220.
5. Makani J, Cox SE, Soka D et al. (2011) Mortality in sickle cell anemia in Africa: a prospective cohort study in Tanzania. PLoS One 6, e14699.
6. Ministry of Health and Social welfare Tanzania (2009) National Strategy for Non-Communicable Diseases 2009-2015. Division of preventative health services, Ministry of Health and Social welfare, Government of the United Republic of Tanzania.
7. Modell B & Darlison M (2008) Global epidemiology of haemoglobin disorders and derived service indicators. Bulletin of the World Health Organization 86, 480-487.
8. Piel FB, Patil AP, Howes RE et al. (2013a) Global epidemiology of sickle haemoglobin in neonates: a contemporary geostatistical model-based map and population estimates. Lancet 381, 142-151.
9. Piel FB, Hay SI, Gupta S, Weatherall DJ & Williams TN (2013b) Global burden of sickle cell anaemia in children under five, 2010-2050: modelling based on demographics, excess mortality, and interventions. PLoS Medicine 10, e1001484.
10. Quinn CT, Rogers ZR & Buchanan GR (2004) Survival of children with sickle cell disease. Blood 103, 4023-4027.
11. Quinn CT, Rogers ZR, McCavit TL & Buchanan GR (2010) Improved survival of children and adolescents with sickle cell disease. Blood 115, 3447-3452.
12. Rahimy MC, Gangbo A, Ahouignan G et al. (2003) Effect of a comprehensive clinical care program on disease course in severely ill children with sickle cell anemia in a sub-Saharan African setting. Blood 102, 834-838.
13. Telfer P, Coen P, Chakravorty S et al. (2007) Clinical outcomes in children with sickle cell disease living in England: a neonatal cohort in East London. Haematologica 92, 905-912.
14. Tshilolo L, Aissi LM, Lukusa D et al. (2009) Neonatal screening for sickle cell anaemia in the Democratic Republic of the Congo: experience from a pioneer project on 31 204 newborns. Journal of Clinical Pathology. 62, 35-38.
15. Vichinsky EP (1991) Comprehensive care in sickle cell disease: its impact on morbidity and mortality. Seminars in Hematology 28, 220-226.
16. Weatherall D, Akinyanju O, Fucharoen S, Olivieri N & Musgrove P (2006). Inherited disorders of hemoglobin. In: Disease Control Priorities in Developing Countries, 2nd edn. (ed. D Jamison ) Oxford University Press, New York, pp. 663-680.
17. Williams TN, Uyoga S, Macharia A et al. (2009) Bacteraemia in Kenyan children with sickle-cell anaemia: a retrospective cohort and case-control study. Lancet. 374, 1364-1370.
18. World Health Organization (2006a) Management of Birth Defects and Haemoglobin Disorders: Report of a Joint WHO-March of Dimes Meeting. World Health Organisation, Geneva, 17-19 May 2006. Report No.
19. World Health Organization(ed.) (2006b) Sickle Cell Anaemia. Agenda item 11.4. 59th World Health Assembly, 27 May 2006; World Health Organisation, Geneva.
20. Yanni E, Grosse SD, Yang Q & Olney RS (2009) Trends in pediatric sickle cell disease-related mortality in the United States, 1983-2002. Journal of Pediatrics 154, 541-545.